{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:43:01Z","timestamp":1786117381883,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001858","name":"Sweden's Innovation Agency","doi-asserted-by":"publisher","award":["2021-02680"],"award-info":[{"award-number":["2021-02680"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det f\u00f6r h\u00e4lsa, arbetsliv och v\u00e4lf\u00e4rd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["2023-00158"],"award-info":[{"award-number":["2023-00158"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.tjpad.2025.100132","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:26:37Z","timestamp":1742199997000},"page":"100132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patient management pathways in dementia \u2013 Resource utilisation, diagnosis and drug treatment in the Stockholm region, Sweden"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7380-1433","authenticated-orcid":false,"given":"Emil","family":"Aho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Religa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6190-3586","authenticated-orcid":false,"given":"Mozhu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0011-1179","authenticated-orcid":false,"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5151-4867","authenticated-orcid":false,"given":"Karin","family":"Modig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100132_bib0001","series-title":"Global status report on the public health response to dementia","year":"2021"},{"key":"10.1016\/j.tjpad.2025.100132_bib0002","series-title":"Dementia in Europe yearbook 2019: estimating the prevalence of dementia in Europe","year":"2019"},{"key":"10.1016\/j.tjpad.2025.100132_bib0003","article-title":"Costs of care in relation to Alzheimer's Disease severity in Sweden: a national registry-based cohort study","author":"Aye","year":"2024","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.tjpad.2025.100132_bib0004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40273-022-01212-z","article-title":"The costs of dementia in Europe: an updated review and meta-analysis","volume":"41","author":"J\u00f6nsson","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.tjpad.2025.100132_bib0005","series-title":"Nationella riktlinjer f\u00f6r v\u00e5rd och omsorg vid demenssjukdom","year":"2017"},{"key":"10.1016\/j.tjpad.2025.100132_bib0006","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jalz.2019.08.198","article-title":"Individualized clinical management of patients at risk for Alzheimer's dementia","volume":"15","author":"Isaacson","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100132_bib0007","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000091790","article-title":"3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy","volume":"21","author":"Winblad","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.tjpad.2025.100132_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe alzheimer disease already receiving DonepezilA randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100132_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jalz.2010.07.001","article-title":"An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom","volume":"8","author":"Getsios","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100132_bib0010","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/gps.2191","article-title":"Clinical and cost effectiveness of services for early diagnosis and intervention in dementia","volume":"24","author":"Banerjee","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100132_bib0011","doi-asserted-by":"crossref","unstructured":"Alzheimer's Association. 2018 Alzheimer's disease facts and figures. 2018; 14: 367\u2013429.","DOI":"10.1016\/j.jalz.2018.02.001"},{"key":"10.1016\/j.tjpad.2025.100132_bib0012","first-page":"889","article-title":"EFNS-ENS\/EAN guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe","volume":"22","author":"Schmidt","year":"2015","journal-title":"Alzheimer's disease"},{"key":"10.1016\/j.tjpad.2025.100132_bib0013","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/ene.12707","article-title":"EFNS-ENS\/EAN guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease","volume":"22","author":"Schmidt","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tjpad.2025.100132_bib0014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100132_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-amyloid monoclonal antibodies for the treatment of Alzheimer's disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.tjpad.2025.100132_bib0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/ADR230007","article-title":"Current diagnostic pathways for Alzheimer's Disease: a cross-sectional real-world study across six countries","volume":"7","author":"Roth","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.tjpad.2025.100132_bib0017","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.tjpad.2025.100132_bib0018","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.tjpad.2025.100132_bib0019","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.tjpad.2025.100132_bib0020","unstructured":"SKR. KPP databas, https:\/\/statva.skr.se\/SASVisualAnalytics\/?reportUri=%2Freports%2Freports%2F1d5e00ee-d616-4334-813e-1722a2ee631c&sso_guest=true&reportViewOnly=true&sas-welcome=false 2024."},{"key":"10.1016\/j.tjpad.2025.100132_bib0021","unstructured":"SKR. KOLADA databse, https:\/\/www.kolada.se\/verktyg\/fri-sokning\/. 2024."},{"key":"10.1016\/j.tjpad.2025.100132_bib0022","series-title":"Posit software","article-title":"RStudio: integrated development for R","year":"2024"},{"key":"10.1016\/j.tjpad.2025.100132_bib0023","doi-asserted-by":"crossref","unstructured":"ALZHEIMER'S ASSOCIATION. 2023 Alzheimer's disease facts and figures. 2023; 19: 1598\u2013695.","DOI":"10.1002\/alz.13016"},{"key":"10.1016\/j.tjpad.2025.100132_bib0024","first-page":"1402","article-title":"Longitudinal analysis of dementia diagnosis and specialty care among racially diverse","volume":"15","author":"Drabo","year":"2019","journal-title":"Medicare beneficiaries"},{"key":"10.1016\/j.tjpad.2025.100132_bib0025","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/jgs.14226","article-title":"Treatment patterns with antidementia drugs in the United States: medicare cohort study","volume":"64","author":"Koller","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.tjpad.2025.100132_bib0026","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1038\/s41598-022-08595-1","article-title":"Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM","volume":"12","author":"Byun","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.tjpad.2025.100132_bib0027","article-title":"The formal care costs of dementia: a longitudinal study using Swedish register data","author":"Zilling","year":"2024","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.tjpad.2025.100132_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100132_bib0029","first-page":"1039","article-title":"Costs of diagnosing dementia: results from","volume":"28","author":"Wimo","year":"2013","journal-title":"SveDem, the Swedish Dementia Registry"},{"key":"10.1016\/j.tjpad.2025.100132_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14283\/jpad.2023.94","article-title":"Estimates of current capacity for diagnosing Alzheimer's Disease in Sweden and the need to expand specialist numbers","volume":"11","author":"Mattke","year":"2024","journal-title":"J Prev Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:39:30Z","timestamp":1786023570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2274580725000767"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100132","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient management pathways in dementia \u2013 Resource utilisation, diagnosis and drug treatment in the Stockholm region, Sweden","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100132"}}